MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
VYNE Therapeutics Inc. Common Stock

VYNE

#3666
VYNE Therapeutics Inc. Common Stock
0.60
+3.45%
Sector:
Base:
Profit Currency:
Daily Range
0.60
0.60
Year Range
0.28
2.60
Daily Change
+3.45%
Monthly Change
+5.26%
6 month change
+87.50%
Year Change
-73.33%
Previous Close
0.58
Open
0.60
Bid
Ask
Low
0.60
High
0.60
Volume
97
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. VYNE
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q4, 25 TTM

News

Investing Investing
VYNE
2025.12.18
VYNE Therapeutics se fundirá com Yarrow Bioscience em acordo de US$ 200 milhões
Investing Investing
VYNE
2025.12.18
VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal
Seeking Alpha Seeking Alpha
VYNE
2025.12.17
VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript
Investing Investing
VYNE
2025.12.17
Ações da Vyne Therapeutics disparam após fusão com a Yarrow Bioscience
Investing Investing
VYNE
2025.12.17
Vyne Therapeutics stock soars after merger with Yarrow Bioscience
Investing Investing
VYNE
2025.12.17
VYNE and Yarrow Bioscience to merge in all-stock transaction
Benzinga Benzinga
GIS VYNE UDMY DBVT PLCE
2025.12.17
Crude Oil Rises Over 1%; General Mills Earnings Top Views - DBV Technologies (NASDAQ:DBVT), General Mills (NYSE:GIS)
Benzinga Benzinga
JBL VYNE ATPC PLCE
2025.12.17
Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Aditxt (NASDAQ:ADTX), Agape ATP (NASDAQ:ATPC)
Zacks Zacks
VYNE TBPH
2025.11.06
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
Zacks Zacks
VYNE CASI
2025.08.14
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
Zacks Zacks
VYNE
2025.08.12
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
Zacks Zacks
AQST VYNE
2025.08.11
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd